Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1982 Aug;79(15):4718–4722. doi: 10.1073/pnas.79.15.4718

Protection against a nonimmunogenic mouse leukemia by an immunogenic variant obtained by mutagenesis.

A Van Pel, T Boon
PMCID: PMC346748  PMID: 6981814

Abstract

The nonimmunogenic thymic leukemia TH, obtained in mouse strain CBA/Ht, was adapted to culture. By in vitro treatment of a clonal TH cell line with the mutagen N-methyl-N'-nitro-N-nitrosoguanidine, stable variant cell clones (tum-) were obtained that elicited a rejection response in syngeneic mice. Mice that had rejected a tum- variant were partially protected against a challenge with the original tumor. When spleen cells of these animals were restimulated in vitro, cytolytic T cells were obtained that were directed against an antigen present on the original tumor. The existence of these cytolytic effectors was confirmed by clonal analysis of the cytolytic response. No immune protection against TH was observed in mice that had been immunized with irradiated cells of the original TH tumor. These results confirm that tum- variants can elicit a syngeneic rejection response against tumors that are apparently devoid of transplantation immunogenicity. The experimental conditions and the results make it likely but not certain that the tumor-associated antigen detected on leukemia TH was present on the primary tumor.

Full text

PDF
4718

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonmassar E., Bonmassar A., Vadlamudi S., Goldin A. Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug. Proc Natl Acad Sci U S A. 1970 Aug;66(4):1089–1095. doi: 10.1073/pnas.66.4.1089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boon T., Kellermann O. Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line. Proc Natl Acad Sci U S A. 1977 Jan;74(1):272–275. doi: 10.1073/pnas.74.1.272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boon T., Van Pel A. Teratocarcinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line. Proc Natl Acad Sci U S A. 1978 Mar;75(3):1519–1523. doi: 10.1073/pnas.75.3.1519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Boon T., Van Snick J., Van Pel A., Uyttenhove C., Marchand M. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis. J Exp Med. 1980 Nov 1;152(5):1184–1193. doi: 10.1084/jem.152.5.1184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brunner K. T., MacDonald H. R., Cerottini J. C. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. II. Analysis of the clonal progeny of CTL precursors stimulated in vitro with syngeneic tumor cells. J Immunol. 1980 Apr;124(4):1627–1634. [PubMed] [Google Scholar]
  6. Galili N., Naor D., Asjö B., Klein G. Induction of immune responsiveness in a genetically low-responsive tumor-host combination by chemical modification of the immunogen. Eur J Immunol. 1976 Jul;6(7):473–476. doi: 10.1002/eji.1830060705. [DOI] [PubMed] [Google Scholar]
  7. Georlette M., Boon T. Immunogenic cell variants of a mouse teratocarcinoma confer a protection against the original non-immunogenic transplantable tumor. Eur J Cancer Clin Oncol. 1981 Oct;17(10):1083–1087. doi: 10.1016/0014-2964(81)90292-9. [DOI] [PubMed] [Google Scholar]
  8. Gillis S., Watson J. Interleukin-2 dependent culture of cytolytic T cell lines. Immunol Rev. 1981;54:81–109. doi: 10.1111/j.1600-065x.1981.tb00435.x. [DOI] [PubMed] [Google Scholar]
  9. Hewitt H. B., Blake E. R. Stability of transplanted murine tumour systems after storage of cells at -196 degrees C for up to 13 years. Br J Cancer. 1978 May;37(5):718–722. doi: 10.1038/bjc.1978.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. KLEIN E., KLEIN G. ANTIGENIC PROPERTIES OF LYMPHOMAS INDUCED BY THE MOLONEY AGENT. J Natl Cancer Inst. 1964 Mar;32:547–568. [PubMed] [Google Scholar]
  11. Kobayashi H., Gotohda E., Hosokawa M., Kodama T. Inhibition of metastasis in rats immunized with xenogenized autologous tumor cells after excision of the primary tumor. J Natl Cancer Inst. 1975 Apr;54(4):997–999. [PubMed] [Google Scholar]
  12. Kobayashi H., Sendo F., Kaji H., Shirai T., Saito H., Takeichi N., Hosokawa M., Kodama T. Inhibition of transplanted rat tumors by immunization with identical tumor cells infected with Friend virus. J Natl Cancer Inst. 1970 Jan;44(1):11–19. [PubMed] [Google Scholar]
  13. Kobayashi H., Sendo F., Shirai T., Kaji H., Kodama T. Modification in growth of transplantable rat tumors exposed to Friend virus. J Natl Cancer Inst. 1969 Mar;42(3):413–419. [PubMed] [Google Scholar]
  14. Leclerc J. C., Gomard E., Levy J. P. Cell-mediated reaction against tumors induced by oncornaviruses. I. Kinetics and specificity of the immune response in murine sarcoma virus (MSV)-induced tumors and transplanted lymphomas. Int J Cancer. 1972 Nov;10(3):589–601. doi: 10.1002/ijc.2910100318. [DOI] [PubMed] [Google Scholar]
  15. MacDonald H. R., Cerottini J. C., Ryser J. E., Maryanski J. L., Taswell C., Widmer M. B., Brunner K. T. Quantitation and cloning of cytolytic T lymphocytes and their precursors. Immunol Rev. 1980;51:93–123. doi: 10.1111/j.1600-065x.1980.tb00318.x. [DOI] [PubMed] [Google Scholar]
  16. Old L. J. Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture. Cancer Res. 1981 Feb;41(2):361–375. [PubMed] [Google Scholar]
  17. PREHN R. T., MAIN J. M. Immunity to methylcholanthrene-induced sarcomas. J Natl Cancer Inst. 1957 Jun;18(6):769–778. [PubMed] [Google Scholar]
  18. Ryser J. E., MacDonald H. R. Limiting dilution analysis of alloantigen-reactive T lymphocytes. I. Comparison of precursor frequencies for proliferative and cytolytic responses. J Immunol. 1979 May;122(5):1691–1696. [PubMed] [Google Scholar]
  19. Uyttenhove C., Van Snick J., Boon T. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice. J Exp Med. 1980 Nov 1;152(5):1175–1183. doi: 10.1084/jem.152.5.1175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Van Pel A., Georlette M., Boon T. Tumor cell variants obtained by mutagenesis of a Lewis lung carcinoma cell line: immune rejection by syngeneic mice. Proc Natl Acad Sci U S A. 1979 Oct;76(10):5282–5285. doi: 10.1073/pnas.76.10.5282. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES